⌘K
Loading ticker…
GRAIL, Inc. Common Stock · Healthcare · Healthcare
As of 2026-06-26, GRAIL, Inc. Common Stock (GRAL) has a 3-month relative strength percentile of 78 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 56. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.7%, relative volume 1.98×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 78, Market Stance is mixed at 47, A/D rating C
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
GRAL is held by 5 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $60M notional. Top 3 carry $158M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $60M |
| XBIState Street SPDR S&P Biotech ETF | 0.72% | $54M |
| IWMiShares Russell 2000 ETF | 0.06% | $44M |
| VXFVanguard Extended Market ETF | 0.02% | $17M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GRAL Jan avg: 41.96% median: 41.96% win: 100% σ: 39.14% n: 2 2024-06-26 → 2026-05-29 | GRAL Feb avg: -9.12% median: -9.12% win: 50% σ: 51.57% n: 2 2024-06-26 → 2026-05-29 | GRAL Mar avg: -18.34% median: -18.34% win: 0% σ: 21.82% n: 2 2024-06-26 → 2026-05-29 | GRAL Apr avg: 20.24% median: 20.24% win: 100% σ: 20.96% n: 2 2024-06-26 → 2026-05-29 | GRAL May avg: 21.46% median: 21.46% win: 100% σ: 14.30% n: 2 2024-06-26 → 2026-05-29 | GRAL Jun avg: 12.14% median: 12.14% win: 50% σ: 30.73% n: 2 2024-06-26 → 2026-05-29 (current) | GRAL Jul avg: -16.70% median: -16.70% win: 50% σ: 23.71% n: 2 2024-06-26 → 2026-05-29 | GRAL Aug avg: -6.20% median: -6.20% win: 0% σ: 2.90% n: 2 2024-06-26 → 2026-05-29 | GRAL Sep avg: 38.92% median: 38.92% win: 50% σ: 58.55% n: 2 2024-06-26 → 2026-05-29 | GRAL Oct avg: 27.05% median: 27.05% win: 50% σ: 40.20% n: 2 2024-06-26 → 2026-05-29 | GRAL Nov avg: 24.52% median: 24.52% win: 100% σ: 6.28% n: 2 2024-06-26 → 2026-05-29 | GRAL Dec avg: -10.23% median: -10.23% win: 50% σ: 17.30% n: 2 2024-06-26 → 2026-05-29 |